[1]
Carbonara, S. 2024. The efficacy of dalbavancin and impact on hospitalization and treatment costs in patients with ABSSSI. Global and Regional Health Technology Assessment. 11, Suppl. 2 (Jul. 2024), 13–17. DOI:https://doi.org/10.33393/grhta.2024.3045.